TALPHERA, INC. 8-K

What Happened On March 11, 2026, Talphera, Inc. announced it received a written notice from the Nasdaq Listing Qualifications Staff saying the company is not in compliance with Nasdaq’s minimum bid price requirement (Listing Rule 5550(a)(2)). The notice does not immediately affect the listing, but Talphera has 180 calendar days to cure the deficiency by achieving a closing bid of at least $1.00 per share for ten consecutive business days before September 7, 2026.

Key Details

• Notice date: March 11, 2026; 180-day compliance period ends September 7, 2026.
• Requirement to cure: closing bid ≥ $1.00 per share for at least 10 consecutive business days.
• Possible second extension: an additional 180-day period may be available if Talphera meets Nasdaq’s market value and other initial listing standards (except the minimum bid price) and notifies Nasdaq that it may use a reverse stock split to cure the deficiency.
• If Nasdaq staff determines the company cannot cure the deficiency or is ineligible, Nasdaq may provide notice of delisting.

Why It Matters This notice signals a risk that Talphera’s shares could be delisted from The Nasdaq Capital Market if the stock price does not recover or the company does not meet extension conditions. Delisting could reduce liquidity and make it harder for investors to trade the stock. Talphera stated it will monitor the closing bid and evaluate options to regain compliance; investors should watch the share price and company updates for any actions (such as a reverse stock split) or further Nasdaq communications.